Article Per Year (5 Year)
p-Index From 2021 - 2026
2.908
P-Index
This Author published in this journals
All Journal Jurnal Kedokteran Jurnal Biologi Tropis Jurnal Ilmu Kedokteran dan Kesehatan Jurnal Respirologi Indonesia Jurnal Respirasi (JR) Jurnal Abdi Insani Narra J Indonesian Journal of Cancer Jurnal Pepadu
Moulid Hidayat
Department Of Pulmonology And Respiratory Medicine, Faculty Of Medicine, University Of Mataram, West Nusa Tenggara Provincial Hospital, Mataram
Religion Agriculture, Biological Sciences & Forestry Biochemistry, Genetics & Molecular Biology Civil Engineering, Building, Construction & Architecture Computer Science & IT Economics, Econometrics & Finance Education Engineering Environmental Science Health Professions Immunology & microbiology Languange, Linguistic, Communication & Media Law, Crime, Criminology & Criminal Justice Mathematics Medicine & Pharmacology Public Health Social Sciences

Published : 16 Documents Claim Missing Document
Claim Missing Document
Check
Articles

Found 16 Documents
Search

 1   2 
Challenges on tuberculosis care in health care facilities during COVID-19 pandemic: Indonesian perspective Winardi, Wira; Wahyuni, Hendra; Hidayat, Moulid; Wirawan, Aditya; Nurwidya, Fariz; Uddin, Mohammad N.; Yusup, Mohamad
Narra J Vol. 2 No. 2 (2022): August 2022
Publisher : Narra Sains Indonesia

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.52225/narra.v2i2.80

Abstract

Indonesia is among the top three countries globally with the highest tuberculosis  burden. During the past decades, Indonesian health authorities have struggled to improve tuberculosis care quality in health care facilities by optimizing the regulation and strengthening the private sector contributions. The coronavirus disease 2019 (COVID-19) pandemic has hardly affected the Indonesian health care system, including the National Tuberculosis Control Program. While the end of the COVID-19 pandemic in Indonesia is uncertain, the measure to control tuberculosis must not be weakened. Early identification and measurement of the problem size are essential to decide the most appropriate approach to maintain the sustainability of National Tuberculosis Control Program, particularly in health care facilities during the COVID-19 pandemic. This article points out the possible threats to the sustainability of TB care in Indonesia during the COVID-19 pandemic, including some approaches to overcome those problems.
Indonesian Society of Respirology Position Paper on Lung Cancer Control in Indonesia Andarini, Sita; Santoso, Andintia Aisyah; Arfiansyah, Mochammad Aris; Syahruddin, Elisna; Zaini, Jamal; Putra, Andika Chandra; Kurniawan, Ferry Dwi; Ermayanti, Sabrina; Soeroso, Noni Novisari; Munir, Sri Melati; Infianto, Andreas; Setijadi, Ana Rima; Setyawan, Ungky Agus; Wulandari, Laksmi; Haryati, Haryati; Jasminarti, Ida Ayu; Hidayat, Moulid; Santoso, Arif
Jurnal Respirologi Indonesia Vol 44, No 4 (2024)
Publisher : Perhimpunan Dokter Paru Indonesia (PDPI)/The Indonesian Society of Respirology (ISR)

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.36497/jri.v44i4.884

Abstract

Lung cancer is a major health concern in Indonesia due to its increasing prevalence, late-stage diagnosis, younger population, and high mortality. Addressing this issue requires nationwide implementation of comprehensive lung cancer control, which includes risk reduction and prevention strategies, focusing on tobacco control and air pollution mitigation. Screening with low-dose computed tomography (LDCT) and early detection in symptomatic patients, along with TB screening programs and all non-communicable diseases, is strongly recommended to enhance early case findings, treatment effectiveness, and overall patient outcomes. A multidisciplinary team (MDT) approach is important to ensure accurate diagnosis and comprehensive care. Moreover, the integration of palliative care at the early stages of advanced lung cancer is vital, focusing on symptom management and enhancing the quality of life for patients. While national guidelines are available for the diagnosis and treatment of lung cancer, significant disparities in healthcare access remain across Indonesia. Thus, it is essential to improve universal health coverage and referral systems to guarantee equal access to lung cancer care for patients at all levels through advocacy and ease of access.
Association of ARDS Severity with Non-Invasive Ventilation Duration in COVID-19 Patients Romadoni, Muhammad Aulia Hikmah; Moulid Hidayat; Bayu Tirta Dirja
Jurnal Biologi Tropis Vol. 25 No. 4 (2025): Oktober-Desember
Publisher : Biology Education Study Program, Faculty of Teacher Training and Education, University of Mataram, Indonesia

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.29303/jbt.v25i4.9959

Abstract

The global spread of Coronavirus disease (COVID-19), worsened by the emergence of new variants such as Delta, has created significant challenges for health systems. One of the severe complications experienced by infected individuals is acute respiratory distress syndrome (ARDS), a condition characterized by pulmonary fluid leakage that leads to impaired oxygenation and respiratory difficulty. Patients with mild ARDS are often managed with non-invasive ventilation (NIV), which provides supplemental oxygen without the need for intubation. This study was conducted to examine whether the severity of ARDS influences the duration of NIV use in COVID-19 patients treated at the West Nusa Tenggara Provincial General Hospital (RSUD) in 2021. A cross-sectional study with a retrospective design was applied, and participants were selected through consecutive sampling. Data were obtained from hospital medical records and analyzed using the independent sample t-test. A total of 46 patients met the inclusion criteria, consisting of 27 males (58.7%) and 19 females (41.3%), with a mean age of 53.9 ± 7.9 years. The mean duration of NIV was 3.26 ± 2.816 days in patients with mild ARDS and 3.65 ± 2.870 days in those with moderate ARDS. Statistical analysis showed no significant difference between the two groups (p = 0.643; p > 0.05). These findings indicate that ARDS severity is not associated with the length of NIV use in COVID-19 patients.
Indonesian Society of Respirology Position Paper on Lung Cancer Control in Indonesia Andarini, Sita; Santoso, Andintia Aisyah; Arfiansyah, Mochammad Aris; Syahruddin, Elisna; Zaini, Jamal; Putra, Andika Chandra; Kurniawan, Ferry Dwi; Ermayanti, Sabrina; Soeroso, Noni Novisari; Munir, Sri Melati; Infianto, Andreas; Setijadi, Ana Rima; Setyawan, Ungky Agus; Wulandari, Laksmi; Haryati, Haryati; Jasminarti, Ida Ayu; Hidayat, Moulid; Santoso, Arif
Jurnal Respirologi Indonesia Vol 44 No 4 (2024)
Publisher : Perhimpunan Dokter Paru Indonesia (PDPI)/The Indonesian Society of Respirology (ISR)

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.36497/jri.v44i4.884

Abstract

Lung cancer is a major health concern in Indonesia due to its increasing prevalence, late-stage diagnosis, younger population, and high mortality. Addressing this issue requires nationwide implementation of comprehensive lung cancer control, which includes risk reduction and prevention strategies, focusing on tobacco control and air pollution mitigation. Screening with low-dose computed tomography (LDCT) and early detection in symptomatic patients, along with TB screening programs and all non-communicable diseases, is strongly recommended to enhance early case findings, treatment effectiveness, and overall patient outcomes. A multidisciplinary team (MDT) approach is important to ensure accurate diagnosis and comprehensive care. Moreover, the integration of palliative care at the early stages of advanced lung cancer is vital, focusing on symptom management and enhancing the quality of life for patients. While national guidelines are available for the diagnosis and treatment of lung cancer, significant disparities in healthcare access remain across Indonesia. Thus, it is essential to improve universal health coverage and referral systems to guarantee equal access to lung cancer care for patients at all levels through advocacy and ease of access.
Intrapulmonary Mature Teratoma Presenting with Trichoptysis: A Rare Case Report Nidzarsyah, Muhammad Mirsa; Hidayat, Moulid; Lestari, Rina; Widiasari, Komang Sri Rahayu; Fathana, Prima Belia; Santosa, Hilda; Kumaladewi, Baiq Ratna; Restuningdyah, Novia Andansari Putri; Arsatt, Maz Isa Ansyori
Indonesian Journal of Cancer Vol 19, No 4 (2025): December
Publisher : http://dharmais.co.id/

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.33371/ijoc.v19i4.1390

Abstract

Introduction: Intrapulmonary teratomas (IPT) are exceptionally rare, with only a handful of cases reported worldwide. The disease may lead to severe outcomes, such as massive hemoptysis, airway compression, and malignant transformation. Several international case reports on IPT focus on the diagnosis and surgical treatment approach. In Indonesia, only one case of intrapulmonary teratoma has been documented and analyzed for its radiological characteristics and anatomical pathology. Here, we present a case of mature IPT treated with surgery and adjuvant chemotherapy. To the best of our knowledge, this case is the second to be reported in Indonesia.Case Presentation: A 28-year-old man presented with a complaint of hemoptysis accompanied by clumps of hair (trichoptysis). Physical examination revealed no abnormalities. Chest X-ray and computed tomography (CT) thorax with contrast showed a right lung mass. The patient underwent lobectomy excision with the postoperative CT scan showing a residual mass. Furthermore, pathological findings confirmed a mature teratoma. Patients were then treated with adjuvant chemotherapy and showed clinical improvement.Conclusions: This case emphasizes the importance of including IPT in the differential diagnosis of hemoptysis, especially when trichoptysis–a rare but distinct symptom–is present. Although imaging tests like contrast-enhanced CT scans are crucial for identifying intrapulmonary masses, histological analysis is necessary for a conclusive diagnosis. The mainstay of treatment persists in surgical removal, and adjuvant chemotherapy may help control any remaining illness. This case emphasizes the importance of early detection and a multidisciplinary approach to enhance patient outcomes because it is one of the few documented IPT cases in Indonesia.
The Role of Artificial Intelligence in Enhancing Lung Cancer Diagnostic Accuracy: A Literature Review Salsabila Dinda Nuril Ishlahi; Teguh Budi Wicaksono; Moulid Hidayat; Arif Darmawardana
Jurnal Respirasi Vol. 12 No. 2 (2026): May 2026
Publisher : Faculty of Medicine Universitas Airlangga

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.20473/jr.v12-I.2.2026.165-174

Abstract

Lung cancer remains the leading cause of cancer-related mortality worldwide, with particularly high incidence in Asia, including Indonesia. The stage at diagnosis is a key determinant of prognosis. Therefore, early and accurate detection is essential to improve survival and quality of life. However, in regions with a high prevalence of infectious diseases such as tuberculosis (TB), diagnostic challenges persist due to overlapping radiographic features that may delay definitive diagnosis and treatment. Recent advancements in artificial intelligence (AI) have introduced promising tools to enhance diagnostic accuracy. Artificial intelligence models, especially those based on deep learning (DL) and convolutional neural networks (CNNs), can automatically detect and classify pulmonary nodules on chest X-rays and computed tomography (CT) scans with remarkable precision. By identifying subtle morphological changes that may be missed by human observers, AI significantly increases sensitivity and reduces interobserver variability. Beyond imaging, computational pathology enables AI to analyze histological slides and molecular profiles, providing faster and more consistent results while alleviating the workload of radiologists and pathologists. Despite these breakthroughs, however, clinical implementation of AI remains limited by data privacy concerns, cybersecurity issues, and the need for large, standardized datasets. Moreover, variations in algorithmic performance across imaging modalities highlight the need for external validation and reproducibility before integration into clinical workflows. This literature review explores the evolving role of AI in lung cancer diagnostics across imaging, pathology, and predictive analytics. Understanding these distinctions is crucial to realizing the full potential of AI in transforming diagnostic precision and improving clinical outcomes.
Co-Authors Aditya Wirawan Aditya Wirawan, Aditya Aldri Frinaldi Ana Rima Setijadi Andarini, Sita Arfiansyah, Mochammad Aris Arif Darmawardana Arif Santoso Arsatt, Maz Isa Ansyori Baskoro, Hario Bayu Tirta Dirja Devi Ramadhona Elisna Syahruddin Ermayanti, Sabrina Fariz, Nurwidya Haryati Haryati Hendra Wahyuni Hilda Santosa I Made Arya Yogiswara Mahayasa Indana Eva Ajmala Indana Eva Ajmala Indri Setiawati Infianto, Andreas Itsna Arifatuz Zulfiyah Jasminarti, Ida Ayu Jurnal Pepadu Kumaladewi, Baiq Ratna Kurniawan, Ferry Dwi Laksmi Wulandari Latifah Mukhlisatunnafsi M. Fardi Anugrah Mohamad Yusup Mohammad N. Uddin Moon Fahira Nidzarsyah, Muhammad Mirsa Noni Novisari Soeroso Prima Belia Fathana Putra, Andika Chandra Putu Diwyandaani Priyahita Restuningdyah, Novia Andansari Putri Rina Lestari Rina Lestari Rina Lestari Romadoni, Muhammad Aulia Hikmah Salsabila Dinda Nuril Ishlahi Sang Ayu Nyoman Putri Pradnyasari Santoso, Andintia Aisyah Setyawan, Ungky Agus Sri Melati Munir Teguh Budi Wicaksono Theophany Margareta Kurniawan Uddin, Mohammad N. Wahyu Sulistya Affarah Wahyuni, Hendra Widiasari, Komang Sri Rahayu Wira Winardi Wira Winardi, Wira Yusup, Mohamad Zaini, Jamal Zulfa Hasyimiyyah Ihtisyam Zulfiyah, Itsna Arifatuz